Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22,672,988
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
17,933,078
-
Shares change
-
+381,220
-
Total reported value, excl. options
-
$875,505,917
-
Value change
-
+$19,714,714
-
Number of buys
-
83
-
Number of sells
-
-80
-
Price
-
$48.78
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q1 2021
193 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q1 2021.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,933,078 shares
of 22,672,988 outstanding shares and own 79.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3,080,512 shares), Conestoga Capital Advisors, LLC (1,896,761 shares), VANGUARD GROUP INC (1,106,343 shares), GENEVA CAPITAL MANAGEMENT LLC (919,575 shares), Copeland Capital Management, LLC (891,325 shares), DIMENSIONAL FUND ADVISORS LP (699,564 shares), STATE STREET CORP (679,320 shares), Ranger Investment Management, L.P. (503,420 shares), Summit Creek Advisors LLC (446,026 shares), and KENNEDY CAPITAL MANAGEMENT, INC. (444,654 shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.